Synthesis of Polyhydroxylated Quinolizidines
(EtOAc-MeOH 5:1, Rf 0.15). The solvent was removed by
evaporation under diminished pressure to a residue, to which was
added 4% NaOMe (3.6 mL). After 2 h at room temperature, the
starting material had disappeared and an intermediate with a slightly
higher Rf was formed. The mixture was continuously stirred
overnight to give a much less polar product. The mixture was diluted
with water and extracted with ethyl acetate. The combined organic
solution was dried and concentrated. Purification by chromatography
(EtOAc to EtOAc/MeOH 5:1) gave compound 8 as a syrup (39
mg, 76%). [R]D: -19.2 (c 2.0, CHCl3). 1H NMR (CDCl3) δ: 0.97
(d, 3H, CH3, J ) 6.8 Hz), 2.00 (dd, 1H, H-1′a, J ) 10.8, 14.8 Hz),
2.18 (ddd, 1H, H-3′a, J ) 2.0, 2.4, 14.0 Hz), 2.26 (bs, 1H, 4-OH),
2.60-2.75 (m, 4H, H-5a, 5b, 1′b, 3′b), 3.10 (ddd, 1H, H-1, J )
4.0, 9.2, 10.8 Hz), 3.23 (dd, 1H, H-2, J ) 2.0, 9.2 Hz), 3.36 (m,
1H, H-4′), 3.75 (m, 1H, H-4), 4.05 (bs, 1H, H-3), 4.50 and 4.74 (d
and d, 1H each, CH2Ph, J ) 11.6 Hz), 4.56 and 5.03 (d and d, 1H
each, CH2Ph, J ) 11.6 Hz), 7.28-7.36 (m, 10 H, 2 × Ph). 13C
NMR (CDCl3) δ: 11.7 (CH3), 44.4 (C-1′), 48.6 (C-3′), 51.8 (C-1),
52.8 (C-5), 56.5 (C-4′), 67.8 (C-4), 72.8 (CH2Ph), 74.6 (CH2Ph),
74.9 (C-3), 83.5 (C-2), 128.0, 128.1, 128.3, 128.8, 137.5, 138.7,
209.2 (C-2′). HRMS: calcd for C24H30 NO4 [M + H] 396.2174,
found 396.2174.
chromatography (EtOAc-hexanes 1:3) afforded ketone 17R as a
1
wax (0.13 g, 35% over three steps). [R]D: +6 (c 4.0, MeOH). H
NMR (CDCl3) δ: 2.75 (dd, 1H, H-1′a, J ) 7.6, 16.8 Hz), 2.82
(dd, 1H, H-1′b, J ) 6.4, 16.8 Hz), 3.17 (bd, 2H, 3′-CH2, J ) 7.2
Hz), 3.31 (dd, 1H, H-5a, J ) 5.6, 12.8 Hz), 3.41 (dd, 1H, H-5b,
J ) 6.8, 12.8 Hz), 3.89 (bs, 1H, H-2), 3.91 (bs, 1H, H-3), 4.15 (m,
1H, H-4), 4.56 (m, 1H, H-1), 4.47 and 4.51 (d and d, 1H each,
CH2Ph, J ) 13.2 Hz), 4.55 and 4.63 (d and d, 1H each, CH2Ph,
J ) 11.8 Hz), 5.12 (d, 1H, H-5′a, J ) 17.2 Hz), 5.18 (d, 1H, H-5′b,
J ) 10.4 Hz), 5.87 (m, 1H, H-4′), 7.28-7.36 (m, 10 H, 2 × Ph).
13C NMR (CDCl3) δ: 41.9 (C-1′), 48.4 (C-3′), 52.7 (C-5), 72.0
(CH2Ph), 72.2 (CH2Ph), 79.3 (C-1), 82.4 (C-4), 85.5 (C-2), 86.4
(C-3), 119.4 (C-4′), 127.8, 127.9, 128.2, 128.6, 127.7, 130.4 (C-
5′), 137.5, 137.8, 206.6 (C-2′). HRMS: calcd for C24H28 N3O4
[M + H] 422.2084, found 422.2088.
The anomeric mixture, 17 with 1:1 R/â ratio, was prepared by
same procedure and used for the one-pot reaction as well. For the
NMR spectra, see the Supporting Information.
Protected Quinolizidines 18 and 19. To a solution of ketone
17R (and 17) (100 mg, 0.238 mmol) in THF-H2O (20:1, 3 mL)
was added Ph3P (100 mg), and the solution was stirred at room
temperature overnight. The solvent was evaporated to a residue,
which was dissolved in 4% NaOMe (3 mL). The mixture was stirred
at room temperature overnight, diluted with water, and extracted
with ethyl acetate. The combined organic solution was dried and
concentrated. Purification by chromatography (hexanes-EtOAc 1:4)
afforded a mixture of 18 and 19 as a syrup in a ratio of 3:1 (55
mg, 59%). HRMS: calcd for C24H30 NO4 [M + H] 396.2174, found
396.2152.
Trihydroxyquinolizidine 9. A mixture of 8 (19 mg, 0.048 mmol)
and 10% Pd-C (50% wet, 20 mg) in MeOH-HOAc (10:1, 5 mL)
was subjected to hydrogenation (40 psi) overnight. The catalyst
was removed by centrifugation, and the solvent was evaporated to
a residue, which was dissolved in water. The product obtained by
lyophilization was dissolved in water, and the solution was adjusted
to pH 8 with 0.1 N NaOH before lyophilization. Purification by
chromatography (EtOAc-MeOH 5:1) gave the final trihydroxylated
quinolizidine 9 as a white solid (8 mg, 77%). [R]D: -6.5 (c 0.1,
1
18 (Major). H NMR (CDCl3) δ: 0.97 (d, 3 H, Me, J ) 6.8
Hz), 1.94 (bd, 1H, H-1′a, J ) 14.0 Hz), 2.12-2.17 (m, 1H, H-3′a),
2.62-2.70 (m, 2H, H-1′b, 5a), 2.76-2.80 (m, 2H, H-3′b, 5b), 3.09
(bd, 1H, H-1, J ) 10.8 Hz), 3.34 (bs, 1H, H-2), 3.44 (m, 1H, H-4′),
3.69 (dd, 1H, H-3, J ) 4.0, 3.2 Hz), 4.12 (m, 1H, H-4), 4.45 and
4.51 (d and d, 1H each, CH2Ph, J ) 12.0 Hz), 4.48 and 4.57 (d
and d, 1H each, CH2Ph, J ) 12.0 Hz), 7.24-7.60 (m, 10H, 2 ×
Ph). 13C NMR (CDCl3) δ:11.9 (CH3), 41.7 (C-1′), 47.9 (C-3′), 52.2
(C-1), 52.5 (C-5), 56.7 (C-4′), 66.0 (C-4), 73.2 (CH2Ph), 73.8 (CH2-
Ph), 75.3 (C-3), 75.8 (C-2), 128.1, 128.2, 128.4, 128.6, 128.7, 128.8,
128.9, 129.0, 137.3, 138.0, 210.1 (C-2′).
1
MeOH). H NMR (D2O) δ: 1.00 (d, 3H, CH3, J ) 6.8 Hz), 2.27
(m, 1H, H-1′a), 2.29 (m, 1H, H-3′a), 2.60 (m, 1H, H-5eq), 2.64
(m, 1H, H-3′b), 2.75 (dd, 1H, H-5ax, J ) 10.8, 10.8 Hz), 2.82 (m,
1H, H-1′b), 2.92 (m, 1H, H-1), 3.44 (dd, 1H, H-2, J ) 2.8, 9.6
Hz), 3.48 (m, 1H, H-4′), 3.87 (m, 1H, H-4), 4.02 (dd, 1H, H-3,
J ) 2.4, 2.8 Hz). 13C NMR (D2O) δ: 10.8 (CH3), 43.2 (C-3′), 47.5
(C-1′), 49.3 (C-5), 52.0 (C-1), 55.9 (C-4′), 66.6 (C-4), 70.3 (C-3),
73.4 (C-2), 214.4 (C-2′). HRMS: calcd for C10H18 NO4 [M + H]
216.1226, found 216.1235.
1
19 (Minor). H NMR (CDCl3, assigned based on 1D-TOCSY)
5-C-(5-Azido-2,3-di-O-benzyl-5-deoxy-R-D-arabinofuranosyl)-
1-penten-4-one (17R). To a solution of aldehyde 14R (0.45 g, 1.26
mmol) in anhydrous THF (5 mL) at -40 °C was dropwise added
a solution of AllylMgBr in diethyl ether (7 mL, 7 mmol). After 5
min at -40 °C, the mixture was stirred at room temperature for 3
h. The reaction was quenched by the addition of 0.5 M HCl, and
the solution was extracted with dichloromethane. The organic phase
was dried and concentrated. Purification by chromatography
(EtOAc-hexanes 1:3) afforded a diastereomeric mixture of 15R
(0.38 g, 76%) as a syrup.
δ: 0.93 (d, 3H, Me, J ) 6.8 Hz), 2.20 (dd, 1H, H-1′a, J ) 10.4,
14.0 Hz), 2.62-2.70 (m, 2H, H-1, 1′b, 5a), 2.76-2.80 (m, 2H,
H-3′b, 5b), 3.09 (bd, 1H, H-1, J ) 10.8 Hz), 3.42 (dd, 1H, H-3,
J ) 3.2, 9.2 Hz), 3.44 (m, 1H, H-4′), 3.58 (dd, 1H, H-2, J ) 8.8,
9.2 Hz), 4.12 (m, 1H, H-4), 4.60 and 4.94 (d and d, 1H each, CH2-
Ph, J ) 12.0 Hz), 4.69 and 4.74 (d and d, 1H each, CH2Ph, J )
12.0 Hz), 7.24-7.60 (m, 10H, 2 × Ph). 13C NMR (CDCl3) δ: 11.2
(CH3), 44.4 (C-1′), 48.5 (C-3′), 54.4 (C-1), 56.5 (C-5), 57.4 (C-
4′), 65.8 (C-4), 72.0 (CH2Ph), 75.3 (CH2Ph), 81.4 (C-2), 82.7 (C-
3), 128.1, 128.2, 128.4, 128.6, 128.7, 128.8, 128.9, 129.0, 138.0,
138.2, 208.7 (C-2′).
To a solution of 15R (0.35 g, 0.88 mmol) in dichloromethane
(15 mL) was added a solution of TsCl (0.35 g, 1.8 mmol) in pyridine
(1.5 mL) at 0 °C. The mixture was kept at 4 °C overnight and then
at room temperature for additional 6 h. The excess amount of TsCl
was destroyed by the addition of MeOH, and the solution was
washed with 0.5 M HCl and brine. The organic phase was dried
and concentrated to a residue. To a solution of above residue in
DMF (15 mL) was added NaN3 (0.3 g). The mixture was stirred at
80 °C for 6 h. Upon cooling, the mixture was diluted by the addition
of water, and the aqueous solution was extracted with ethyl acetate.
The combined organic phase was dried and concentrated to azide
16R as a syrup.
Trihydroxyquinolizidines 20 and 21. A mixture of 18/19 (24
mg, 0.06 mmol) and 10% Pd-C (50% wet, 20 mg) in MeOH-
HOAc (10:1, 5 mL) was subjected to hydrogenation (40 psi)
overnight. The catalyst was removed by centrifugation, and the
solvent was evaporated. The residue was dissolved in water and
lyophilized. The solid obtained was redissolved in water, and the
solution was adjusted to pH 8 with 0.1 N NaOH and lyophilized
again to give crude product. Purification by chromatography
(EtOAc-MeOH 5:1) gave the final product 20/21 as a white solid
(9 mg, 69%). HRMS: calcd for C10H18 NO4 [M + H] 216.1235,
found 216.1221.
1
To a solution of above syrupy 16R in dichloromethane (20 mL)
were added NaOAc (0.2 g), 4 Å molecular sieves (0.4 g), and PCC
(0.4 g, 1.86 mmol) at room temperature. The mixture was stirred
for 5 h, and the filtrate was washed and dried. Purification by
20 (Major). H NMR (CDCl3) δ: 1.04 (d, 3H, Me, J ) 6.8
Hz), 2.22-2.28 (m, 2H, H-1′a, 3′a), 2.64-2.90 (m, 4H, H-1′b, 3′b,
5a, 5b), 3.24 (bs, 1H, H-1), 3.48 (m, 1H, H-4′), 3.75 (bs, 1H, H-2),
3.96 (bs, 1H, H-3), 4.14 (m, 1H, H-4). 13C NMR (CDCl3) δ: 11.0
J. Org. Chem, Vol. 72, No. 4, 2007 1233